ltrasound criteria to evaluate for early response to neoadjuvant chemotherapy in breast cancer
Not Applicable
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000003478
- Lead Sponsor
- Japan Association of Breast and Thyroid Sonology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
No remarkable criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ltrasound criteria to evaluate for early response to neoadjuvant chemotherapy in breast cancer was made. The rate of the responder and the non-responder in this criteria is compare to the rate pCR at surgery.
- Secondary Outcome Measures
Name Time Method Quality control of the ultrasound criteria to evaluate for early response to neoadjuvant chemotherapy in breast cancer.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What ultrasound criteria correlate with molecular response markers in breast cancer neoadjuvant therapy?
How does ultrasound-based early response assessment compare to MRI in predicting neoadjuvant chemotherapy outcomes for breast cancer?
Which biomarkers (ER, PR, HER2) correlate with ultrasound criteria for early neoadjuvant chemotherapy response in breast cancer subtypes?
What strategies use ultrasound criteria to monitor and manage adverse events during breast cancer neoadjuvant chemotherapy?
How do JPRN-UMIN000003478 ultrasound criteria inform treatment adjustments for HER2-positive or triple-negative breast cancer during neoadjuvant chemotherapy?